← Browse by Condition
Medical Condition

relapsed or refractory multiple myeloma rrmm

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 3
NCT06615479 Phase 3
Recruiting

A Study to Compare the Efficacy and Safety of BMS-986393 Versus Standard Regimens in Adult Participants With Relapsed or Refractory and Lenalidomide-exposed Multiple Myeloma (QUINTESSENTIAL-2)

Enrollment
440 pts
Location
United States, Argen...
Sponsor
Juno Therapeutics, Inc., a Bri...
View Trial →